Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Open-label TMC125 in HIV-1 infected subjects from prior TMC125 trials
2004-001658-10Phase 2Completed
- Sponsor
- Tibotec
- Start
- Apr 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of etravirine in Human immunodeficiency virus infection type 1, sponsored by Tibotec. Primary endpoint: Long-term safety and tolerability of TMC125. Started Apr 2005; status: completed.
02
Drugs
etravirine
03
Conditions
Human immunodeficiency virus infection type 1
Beyond the preview
Go deeper on 2004-001658-10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-001658-10.